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neurons are thought to lack chloride
extrusionmediated by K-Cl cotransporter
KCC2. Spoljaric et al. demonstrate that
KCC2 restrains the depolarizing
GABAergic synaptic drive onto CA3
pyramidal neurons in perinatal mice and
rats and thereby regulates spontaneous
hippocampal network events (GDPs)
from their developmental onset.
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It is generally thought that hippocampal neurons of
perinatal rats and mice lack transport-functional K-Cl
cotransporter KCC2, and that Cl regulation is domi-
nated by Cl uptake via the Na-K-2Cl cotransporter
NKCC1. Here, we demonstrate a robust enhancement
of spontaneous hippocampal network events (giant
depolarizing potentials [GDPs]) by the KCC2 inhibitor
VU0463271 in neonatal rats and late-gestation, wild-
type mouse embryos, but not in their KCC2-null
littermates. VU0463271 increased the depolarizing
GABAergic synaptic drive onto neonatal CA3 pyrami-
dal neurons, increasing their spiking probability and
synchrony during the rising phase of a GDP. Our
data indicate that Cl extrusion by KCC2 is involved
in modulation of GDPs already at their developmental
onset during the perinatal period in mice and rats.INTRODUCTION
Giant depolarizing potentials (GDPs) are the most pronounced
network activity pattern in the perinatal mouse and rat hippocam-
pus (Ben-Ari et al., 1989, 2007; Sipilä et al., 2005; Spoljaric et al.,
2017; Griguoli andCherubini, 2017).With CA3as their pacemaker
region (Sipilä et al., 2005), GDPs target neighboring areas and
propagate along the septo-temporal axis of the developing hip-
pocampus (Leinekugel et al., 1998; Ben-Ari et al., 2007). These
remarkable spatiotemporal properties point to a crucial role for
GDPs in the activity-dependent establishment of the evolution-
arily encoded framework of hippocampal connectivity, akin to
spontaneous activity in, for instance, the developing visual sys-
tem (cf. Blankenship and Feller, 2010). GDPs are driven by the
intrinsic pacemaker properties of CA3 pyramidal neurons and
by the synergistic actions of glutamate and depolarizing GABA
(Ben-Ari et al., 1989, 2007; Sipilä et al., 2005; Khazipov et al.,
2015; Griguoli and Cherubini, 2017; Kirmse et al., 2018). The
depolarizing GABAergic drive onto pyramidal neurons (Ben-Ari
et al., 1989, 2007) is brought about by active uptake of Cl by
the Na-K-2Cl cotransporter NKCC1 (Dzhala et al., 2005; Sipilä
et al., 2006, 2009; Spoljaric et al., 2017). In the rat hippocampus,Cell Rep
This is an open access article under the CC BY-NGDPs disappear by the end of the second postnatal week (Kha-
zipov et al., 2004; Tyzio et al., 2007; Ben-Ari et al., 2007), in
parallel with the increasing expression of hippocampal KCC2,
the consequent fall in intraneuronal Cl concentration, and the
negative shift in EGABA (Rivera et al., 1999; Tyzio et al., 2007; Kaila
et al., 2014). However, GABAAR signaling has been shown to
exert dual, enhancing and suppressing, effects on hippocampal
network events as early as postnatal day (P) 0–P2 in the rat (Kha-
lilov et al., 1999; Lamsa et al., 2000). Notably, pharmacological
blockade of GABAARs results in the emergence of interictal-like
network activity in the neonatal rat and fetal macaque (Khalilov
et al., 1997b, 1999; Lamsa et al., 2000; Khazipov et al., 2001).
This indicates that, in addition to providing a depolarizing drive,
GABAergic inputs onto hippocampal pyramidal neurons mediate
shunting inhibition of glutamatergic currents during GDPs (Khali-
lov et al., 2015). However, as explained in detail elsewhere (Kaila
et al., 2014), effective shunting is sustainable in a neuron only if
there is a mechanism for active Cl extrusion because, in its
absence, the conductive Cl loads generated during neuronal
activity (Buzsáki et al., 2007) would lead to a progressive depola-
rizing EGABA shift, eventually giving rise to pathophysiological
manifestations (see, e.g., Nardou et al., 2011).
Here, we demonstrate a robust enhancement of GDPs by the
KCC2 inhibitor VU0463271 (Delpire et al., 2012; Sivakumaran
et al., 2015) in neonatal rats and wild-type mice as early as
embryonic day (E) 17.5. Importantly, VU0463271 did not affect
GDPs in KCC2/ littermates. VU0463271 increased the spiking
rates of CA3 pyramidal neurons, but not of the interneurons tar-
geting these pacemaker cells. Somatic whole-cell Cl loading
experiments revealed the ability of perinatal CA3 pyramidal neu-
rons to actively extrude Cl in a KCC2-dependent manner. Phar-
macological inhibition of KCC2 enhanced the depolarizing
GABAergic synaptic drive onto neonatal CA3 pyramidal neu-
rons, as seen in gramicidin-perforated patch recordings, and
increased their synchronous firing during the rising phase of a
GDP. Our data demonstrate that KCC2 has an important role
in restraining GDPs already at their developmental onset.
RESULTS
KCC2 Modulates GDPs in the Perinatal Hippocampus
GDPs first appear in the mouse and rat hippocampus
perinatally (Khazipov et al., 2004; Crépel et al., 2007; Spoljaricorts 26, 1073–1081, January 29, 2019 ª 2019 The Author(s). 1073
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. KCC2 Modulates GDPs in the
Perinatal Rodent Hippocampus
(A) Effect of the specific KCC2 inhibitor
VU0463271 (10 mM) on GDPs in the perinatal rat
(P0–P2) and mouse (E17.5–E18.5) hippocampal
CA3 area. From left to right: magnified example
events from rat, KCC2+/+, and KCC2/ mouse
local field potential (LFP) recordings (filtered
1–10Hz); sample LFP traces (filtered 1–10Hz); and
quantification of normalized network activity
after application of VU0463271 are shown. Data
are presented as median and IQR; Wilcoxon
signed-rank test was used for statistical analysis;
**p < 0.01; N.S., non-significant; n values are
indicated in the bar diagram.
(B) KCC2 expression in E18.5mouse hippocampal
CA3 area of KCC2+/+ and KCC2/ mice. In both
panels, the areas indicated with rectangles (left)
are shown as magnified insets (right). Examples of
KCC2-expressing cells are indicated with stars.
See also Figures S1, S2, and S3.et al., 2017). To study the possible role of KCC2 in the modu-
lation of GDPs around their developmental onset, we used
E17.5–E18.5 mice and P0–P2 rats, which are at a similar level
of cortical development (Clancy et al., 2001; Li et al., 2002).
P5 rats served as a positive control, as this is the earliest
time point when functionally significant levels of transport-
active KCC2 have thus far been reported to be present in the
rat hippocampus (Khirug et al., 2010). In P5 rat hippocampal
slices, the KCC2 inhibitor VU0463271 (10 mM) induced a sus-
tained increase (fold change 2.44; interquartile range [IQR]
1.80–3.93; n = 7; p = 0.018; Figure S1) in the total area of the
local field potential (LFP) events as a function of time, which
takes into account the changes in both frequency and ampli-
tude of the events (Spoljaric et al., 2017). Strikingly,
VU0463271 induced a similarly robust, sustained increase
(fold change: 2.57; IQR 1.90–3.52; n = 14; p = 0.001; Figure 1A)
in slices from P0–P2 rats. GDPs recorded in the presence of
VU0463271 were fully blocked by the NKCC1 inhibitor bumeta-
nide (10 mM) at all ages studied (n = 11; Figure S2), indicating
that the network events recorded in the presence of
VU0463271 are dependent on depolarizing GABA.
In line with a previous report (Khalilov et al., 2011) and the
above pharmacological data, genetic ablation of KCC2, as
seen in intact hippocampi prepared from E17.5–E18.5 KCC2/
mice, resulted in a marked increase in median GDP amplitude,
which was significantly higher in KCC2/ mice compared to
KCC2+/+ littermates (50.7 mV [IQR 42.8–77.8 mV] in KCC2/
[n = 10] versus 33.4 mV [IQR 23.1–52.7 mV] in KCC2+/+ [n = 11];
p = 0.008; Mann-Whitney U test; see sample traces in Figure 1A).1074 Cell Reports 26, 1073–1081, January 29, 2019No difference was observed in the me-
dian frequency of GDPs between the
two genotypes (0.0096 Hz [IQR 0.0048–
0.016 Hz] in KCC2/ [n = 10] versus
0.0075 Hz [IQR 0.0058–0.0208 Hz] in
KCC2+/+ [n = 11]; p = 0.512; Mann-
Whitney U test). Immunohistochemical
analysis verified KCC2 expression in theCA3 area of E18.5 mouse hippocampi (Figure 1B; see also
Khalilov et al., 2011).
Although significant improvement in the specificity of the
KCC2 inhibitor VU0463271 (Delpire et al., 2012; Sivakumaran
et al., 2015) has been achieved with regard to the potency and
ancillary pharmacology of the non-selective parent compound
VU0240551 (Delpire et al., 2009), no knockout validation of
VU0463271 has thus far been performed. To test whether the
enhancement of GDPs by VU0463271 is indeed mediated by
specific inhibition of KCC2, we used intact hippocampi from
E17.5–E18.5 KCC2/ and KCC2+/+ embryos. In line with the
idea that VU0463271 exerts its action by inhibition of KCC2,
GDP activity was markedly increased by the drug in KCC2+/+
(fold change: 2.53; IQR 1.99–2.98; n = 11; p = 0.003), but not
in KCC2/ mice (fold change: 0.88; IQR 0.65–1.17; n = 10;
p = 0.285; Figure 1A; see also Figure S3). As shown previously
by Khalilov et al., 2011 using bicuculline, GDPs were abolished
by blockade of GABAARs with picrotoxin (100 mM) in both
KCC2+/+ and KCC2/ hippocampi (n = 6, each genotype;
data not shown).
Inhibition of KCC2 IncreasesGABA-Driven Spontaneous
Spiking of Pyramidal Neurons
Because both principal cells and GABAergic interneurons are
recruited during GDPs (Sipilä et al., 2005; Ben-Ari et al., 2007;
Picardo et al., 2011), changes in the activity of either or both
cell types could explain the enhancement of GDPs induced by
VU0463271. KCC2 immunohistochemistry in perinatal GAD67-




Figure 2. Inhibition of KCC2 Increases GABA-Driven Spontaneous Spiking in CA3 Pyramidal Neurons, but Not in Interneurons
(A) KCC2 expression in E18.5 GAD67-GFP mouse hippocampal CA3 area. The areas indicated with rectangles (left) are shown in more detail on the right.
Examples of KCC2-expressing interneurons and pyramidal neurons are indicated with arrowheads and stars, respectively.
(B) Scheme of experimental paradigm to record interneuronal activity from a pyramidal neuron (left). Sample traces of a whole-cell voltage-clamp recording
(middle) andmedian of the normalized frequency values (right) of sIPSCs recorded from pyramidal neurons before and after the application of VU0463271 (10 mM)
are shown.
(C) Scheme of experimental paradigm to record pyramidal neuron activity in loose cell-attached configuration (left). Sample traces of a loose cell-attached
recording of CA3 pyramidal neuron spiking (middle) and median of the normalized spike frequency (right) in the presence and absence of VU0463271 and
picrotoxin (100 mM) are shown. Recordings in (B) and (C) were done in the presence of CNQX (10 mM) and D-AP5 (20 mM), indicated in the figure as iGluR block.
Data are presented as median and IQR; Wilcoxon signed-rank test was used for statistical analysis; *p < 0.05; **p < 0.01; n values are indicated in the bar
diagrams.with distinct KCC2 expression were non-GABAergic (Figure 2A).
Analysis of KCC2 immunoreactivity in E18.5–P1 mouse CA3
showed that a total of 89 of 290 principal neurons and 48 of
300 interneuron somata were KCC2 positive (pooled data from17 slices). When evaluating data of this kind in a functional
context, it should be noted that KCC2 molecules may reside in
a kinetically inactive state (Rinehart et al., 2009; Khirug et al.,
2010) or serve ion-transport-independent functions (Kaila et al.,Cell Reports 26, 1073–1081, January 29, 2019 1075
2014). Furthermore, the data above does not take into account
KCC2 expressed in the distal dendritic compartments of pyrami-
dal neurons (Gulyás et al., 2001). To shed light on the KCC2 pool
involved in modulation of GDPs, we differentially examined the
effect of VU0463271 on pyramidal cells and those interneurons
that are synaptically coupled to CA3 pyramidal neurons in the
slice. To this end, we assessed the effects of VU0463271 in loose
cell-attached recordings of pyramidal spiking and in whole-cell
recordings of spontaneous inhibitory postsynaptic currents
(sIPSCs) from P0–P2 rat CA3 pyramidal neurons in the presence
of ionotropic glutamate receptor blockers (iGluR block: CNQX
10 mM, D-AP5 20 mM). VU0463271 induced no changes in sIPSC
frequency (fold change: 0.91; IQR 0.85–1.09; n = 7; p = 0.499;
Figure 2B), whereas it increased the spontaneous spiking of
pyramidal neurons (Friedman’s test; p = 0.001; fold change:
1.36; IQR 1.23–2.21; n = 10; p = 0.007; Figure 2C). The
GABAAR antagonist picrotoxin suppressed the spontaneous
spiking of pyramidal neurons in the presence of VU0463271
and iGluR blockers (fold change compared to control: 0.22;
IQR 0.07–0.34; n = 8; p = 0.012; Figure 2C), suggesting that
the effect of VU0463271 is due to changes in the driving force
of GABAAR-mediated currents.
VU0463271-Sensitive Chloride Extrusion in Neonatal
CA3 Pyramidal Neurons
Previous work, employing gramicidin-perforated patch record-
ings, showed no difference in somatic steady-state EGABA be-
tween KCC2+/+ and KCC2/ mouse CA3 pyramidal neurons
at E18.5 (Khalilov et al., 2011). Such data, obtained under con-
ditions with no constant Cl load, revealed a vast cell-to-cell
heterogeneity in the intracellular somatic Cl levels (see also
Lombardi et al., 2018). This variation may reflect differences in
the functional expression levels of both Cl importing and
extruding proteins. Using a somatic Cl loading technique
(Khirug et al., 2005; Li et al., 2007; Puskarjov et al., 2015,
2017), we found previously that EGABA levels of GABAAR-medi-
ated currents recorded in the presence of the NKCC1 inhibitor
bumetanide and evoked at 50–100 mm from the soma of hippo-
campal neurons reflect a steep increase in KCC2-mediated Cl
extrusion during the first two weeks of postnatal development in
mouse and rat (Khirug et al., 2005; Spoljaric et al., 2017). Under
a defined somatically imposed Cl load and NKCC1 block, we
observed in P1 rat CA3 pyramidal neurons a negligible deviation
of the EGABA, determined using GABA uncaging, from the calcu-
lated passive Cl distribution (EGABA-GHK; see STAR Methods) at
the soma (DEGABA = EGABA  EGABA-GHK = 0.8 mV; IQR 1.2 to
0.4 mV) and at a distance of 50 mm in the apical dendrite
(DEGABA = 3.1 mV; IQR 3.7 to 2.4 mV; n = 4 each; Figures
3A and 3B). This level of the DEGABA recorded at 50 mm from the
soma of P1 CA3 pyramids is, in fact, similar to that recorded in
more mature hippocampal and neocortical pyramidal neurons
following pharmacological block of K-Cl cotransport (Spoljaric
et al., 2017) or genetic deletion of KCC2 (Li et al., 2007; Puskar-
jov et al., 2017). In contrast, and as expected in light of the
developmental upregulation of KCC2 during the first two weeks
of rat hippocampal postnatal development (Khirug et al., 2005;
Spoljaric et al., 2017), a large negative shift in dendritic EGABA
at 50 mmwas observed in P17 CA3 pyramidal neurons (DEGABA =1076 Cell Reports 26, 1073–1081, January 29, 20199.9 mV; IQR 11.7 to 9.7 mV; p = 0.02 compared to P1;
Mann-Whitney U test; not illustrated), and somatic EGABA was
still close to EGABA-GHK (DEGABA = 2.0 mV; IQR 2.1 to
1.5 mV; n = 5 each; not illustrated). To examine whether a sig-
nificant level of KCC2-mediated K-Cl cotransport can be de-
tected in the perinatal CA3 pyramidal neurons, we improved
the sensitivity of our Cl extrusion assay by recording dendritic
EGABA values at a larger distance, 200 mm, from the soma (Fig-
ures 3A–3C). This approach uncovered the presence of KCC2-
mediated Cl extrusion in CA3 pyramids at P1 as indicated
by the VU0463271-mediated positive shift in DEGABA (Ctrl:
DEGABA = 11.3 mV [IQR 16.9 to 9.9 mV]; VU0463271:
DEGABA = 6.3 mV [IQR 6.6 to 3.5 mV]; n = 5; p = 0.04; Fig-
ures 3B and 3C). These data demonstrate that neonatal CA3
pyramidal neurons are able to actively extrude Cl in a KCC2-
dependent manner in the dendrites below the level set by
passive distribution. Obviously, this does not exclude the
presence of Cl extrusion mechanisms in the somatic compart-
ment. Moreover, the above approach based on exogenous
(uncaged) GABA does not provide information on whether the
observed Cl extrusion occurs at GABAergic synapses. To
investigate how pharmacological inhibition of KCC2 affects
the driving force of synaptic GABAAR-mediated currents
(DFGABA) under conditions of otherwise unperturbed Cl
 ho-
meostasis, we performed gramicidin-perforated patch record-
ings of miniature inhibitory postsynaptic currents (mIPSCs) at
resting membrane potential in the absence of bumetanide.
These experiments demonstrated a VU0463271-induced in-
crease in mIPSC amplitude (fold change: 1.50; IQR 1.15–2.04;
p = 0.018; Figure 3D), which was not seen in the controls (ampli-
tude fold change: 1.10; IQR 0.79–1.19; p = 0.5; Figure 3D). The
above results demonstrate an enhanced depolarizing synaptic
GABAergic drive after selective pharmacological inhibition of
KCC2.
Inhibition of KCC2 Shifts the Spike Distribution of CA3
Pyramidal Neurons toward the Rising Phase of GDPs
GDPs act to synchronize neuronal firing in the CA3 pyramidal cell
layer (Khalilov et al., 2015). After establishing that VU0463271 in-
creases DFGABA (Figure 3) and the GABA-driven spontaneous
spiking of CA3 pyramidal neurons (Figure 2), we examined the ef-
fects of KCC2 inhibition on GDP-nested spiking of the CA3 pyra-
midal neurons. Because the depolarizing GABAergic drive is
crucial in shaping GDPs (Ben-Ari et al., 1989; Sipilä et al.,
2005; Valeeva et al., 2013; Spoljaric et al., 2017), inhibition of
KCC2 is expected to increase the network-level synchronization
of pyramidal neurons (see below). In simultaneous loose cell-
attached andmulti-unit activity (MUA) recordings of CA3 pyrami-
dal neuron spiking, the overall number of GDP-nested spikes did
not change significantly during VU0463271 application (loose
cell-attached, fold change: 1.16 [IQR 0.97–1.4], n = 6, p = 0.16;
MUA, fold change: 0.77 [IQR 0.7–1.12], n = 6, p = 0.44; Figures
4A and 4D). However, the relative number of spikes during the
rising phase of GDPs in comparison to the total number of
GDP-nested spikes was significantly increased during
VU0463271 application in both loose cell-attached and MUA re-
cordings (loose cell-attached, control: 0.36 [IQR 0.14–0.56]



































































































Figure 3. VU0463271-Sensitive Chloride
Extrusion in Neonatal CA3 Pyramidal
Neurons
(A) An Alexa Fluor 488-filled CA3 pyramidal neuron
from a P1 rat representing the position of the
whole-cell patch pipette imposing a 19 mM Cl
load onto the neuron and the sites of UV photolysis
of caged GABA.
(B) Chloride extrusion efficacy in P1 rat CA3
pyramidal neurons determined using local UV
photolysis of caged GABA at the soma (n = 4) and
apical dendrite at 50 mm (n = 4) and 200 mm (n = 5)
distance from the somatic Cl load, under control
conditions (black) and in the presence of
VU0463271 (10 mM, gray). Stippled line delimits
the approximate residual negative deflection in
EGABA from EGABA-GHK at 50 mm that is insensitive
to VU0463271 (see Spoljaric et al., 2017) and
present in KCC2/ neurons (see Li et al., 2007).
(C) Sample EGABA recordings and their corre-
sponding I-V plots in the presence of iGluR block
and bumetanide (2.5 mM).
(D) Sample traces of gramicidin-perforated patch
recordings (left) and median of the normalized
amplitude of miniature inhibitory postsynaptic
currents (mIPSCs; right) recorded from pyramidal
neurons before and after the application of
VU0463271 or DMSO. Recordings were done in
the presence of iGluR block and TTX (0.5 mM).
Data in (B) and (D) are presented as median
and IQR; Wilcoxon signed-rank test were used
for statistical analysis; *p < 0.05; n values are
indicated in the bar diagram.MUA, control: 0.30 [IQR 0.24–0.34] versus VU0463271: 0.43 [IQR
0.30–0.60], n = 6, p = 0.031; Figures 4A–4D). This shows that the
VU0463271-induced increase in DFGABA leads to increased syn-
chronization of pyramidal neuron spiking during the rising phase
of GDPs.
Collectively, our data indicate that KCC2-mediated Cl extru-
sion acts to limit the depolarizing GABAergic drive in the peri-
natal hippocampus of both rat and mouse, which readily
explains the VU0463271-induced increase in spontaneous
network activity.
DISCUSSION
The main finding of the present study is that transport-functional
KCC2 is expressed at physiologically significant levels in perinatal
CA3 pyramidal neurons of rats and mice, i.e., at a surprisingly
early stage of hippocampal development. KCC2 mRNA has
been observed in the mouse CA3 as early as E15.5 (Stein et al.,
2004), andworkonE18.5mouseembryos reportedamodest level
of KCC2 immunoreactivity in CA3 pyramidal neurons (Khalilov
et al., 2011). The role of this early KCC2 expression has remained
poorly defined. In the present work, we found that KCC2 has an
important role in restraining GDPs in neonatal mice and rats byCell Repoopposing Cl uptake via NKCC1, which
at this developmental stage is dominant
and maintains GABAAR-mediated cur-rents strongly depolarizing (Sipilä et al., 2006, 2009; Pfeffer
et al., 2009; Khazipov et al., 2015; Spoljaric et al., 2017). In
P0–P2 rat hippocampal slices, inhibition ofKCC2 increased spon-
taneous spiking of CA3 pyramidal neurons as well as their syn-
chrony during the rising phase of a GDP, with no significant effect
on the number of GDP-nested spikes. In agreement with the idea
that KCC2 acts to suppress GDP activity, we observed that these
events had a higher amplitude in KCC2-null versus wild-type ani-
mals, and this difference was closely mimicked by exposure of
wild-type mouse hippocampi to the KCC2 blocker VU0463271.
Based on our data on KCC2+/+ versus KCC2/ mouse embryos,
VU0463271 used at 10 mM shows a high level of specificity,
because it does not seem to haveoff-target effects on themultiple
molecular mechanisms that are involved in the generation of
GDPs (Ben-Ari et al., 2007; Griguoli and Cherubini, 2017).
We found using whole-cell recordings that rat neonatal CA3
pyramidal neurons are equipped with a sufficient amount
of functional KCC2 to counteract a constant experimentally
imposed Cl load. Furthermore, using gramicidin-perforated
patch recordings, we demonstrated that KCC2 expressed at
this age in CA3 pyramids maintains a less depolarizing driving
force of synaptic GABAAR-mediated currents than the one




Figure 4. Inhibition of KCC2 Shifts the Spike
Distribution of CA3 Pyramidal Neurons
toward the Rising Phase of GDPs
(A) Sample traces from simultaneous loose cell-
attached (top) and local field potential (LFP) re-
cordings (middle: multi-unit activity [MUA], band-
pass 400-2000 Hz; bottom: GDP, bandpass 1-10
Hz) of CA3 pyramidal neuron spiking in the absence
and presence of VU0463271 (10 mM). The colored
boxes over the sample traces highlight the rising
phase (green) and falling phase (red) of the GDP.
(B and C) Example raster plots of CA3 pyramidal
neuron spiking during 10 control GDPs and
10 GDPs during VU0463271 application from
a simultaneous loose cell-attached recording of
spiking (B) and LFP recording ofMUA (C). The peak
of the GDPs is set to time point 0 s. The mock GDP
shape in thebackgroundof the raster plotsportrays
the rising and falling phases of the GDPs.
(D) Median values of normalized GDP-nested
spikes in both loose cell-attached and MUA
recordings during VU0463271 (left). Number of
spikes observed in loose cell-attached and MUA
recordings during the rising phase of GDPs, in
relation to the total number of GDP-nested spikes,
in the absence and presence of VU0463171 (right)
is shown. Data are presented as median and IQR;
Wilcoxon signed-rank test was used for statistical
analysis; *p < 0.05; n values are indicated in the bar
diagrams.Recent work on neonatal rat CA3 pyramidal neurons suggests
that GABAergic actions change dynamically from depolarizing
to hyperpolarizing during GDPs, which is thought to prevent
epileptiform synchronization in the recurrent CA3 network (Khali-
lov et al., 2015). According to this scheme, at the onset of a GDP,
the excitatory inward current is driven by depolarizing NKCC1-
dependent GABAAR-mediated and by glutamatergic synaptic
currents as shown in a number of studies (reviewed by Ben-Ari
et al., 2007). However, at thepeak of aGDP,when themomentary
membrane potential is depolarized beyond EGABA, IGABA tran-1078 Cell Reports 26, 1073–1081, January 29, 2019siently switches its polarity (Khalilov
et al., 2015) to becomean outward current
enabling effective shunting (see Kaila
et al., 2014) of the glutamatergic input via
simultaneously open GABAARs (Khalilov
et al., 2015). In the absence of active Cl
extrusion, conductive Cl loading during
neuronal network activity would lead to a
progressive, uncontrolled depolarizing
EGABA shift (Kaila et al., 2014) and, conse-
quently, to epileptiform activity. Indeed,
downregulation of KCC2 in an in vitro
model of neonatal seizures has been
shown to result in accumulation of intra-
cellular Cl, thereby contributing to the
aggravation of epileptiform activity by
phenobarbital (Nardou et al., 2011).
Althoughwe found that the KCC2 inhib-
itor VU0463271 increased the firing rate ofP0–P2 rat hippocampal CA3 pyramidal neurons in the absence
of glutamatergic transmission, we observed no change in the
output of interneurons synapsing onto pyramidal neurons.
Immature pyramidal neurons have been reported to receive
GABAergic innervation predominantly onto their dendrites (Tyzio
et al., 1999; Khazipov et al., 2001; Morozov and Freund, 2003).
Indeed, CA3 pyramidal dendrites were presently found to be
equipped with transport-functional KCC2 at a level sufficient to
oppose a significant Cl load. Hippocampal interneurons consti-
tute a developmentally and functionally heterogeneous cell
population and, not surprisingly, diverse actions of GABA on
neonatal interneurons have been reported (Leinekugel et al.,
1995; Khazipov et al., 1997; Bolea et al., 1999; Verheugen
et al., 1999; Banke and McBain, 2006; Tyzio et al., 2008; Sauer
and Bartos, 2010). Recent work on early-born GABAergic hub
neurons—a subpopulation of CA3 interneurons critical for regu-
lation of hippocampal spontaneous network events (Bonifazi
et al., 2009; Picardo et al., 2011)—reported no expression of
KCC2 between E18.5 and P1, and at P2–P4, less than ten
percent of them are KCC2 positive (Villette et al., 2016). In
embryonic mouse neocortical explants grown in vitro, KCC2
expression has been reported to be predominantly interneuronal
(Bortone and Polleux, 2009). The above is apparently not the
case for the perinatal hippocampal CA3 area ex vivo, where
higher KCC2 expression was observed in the pyramidal neurons
than in interneurons.
In studies on perinatal rats and mice, which are by far the
most widely used animals in biomedical research, it is some-
times overlooked that the level of brain maturation at birth
shows extensive variation among mammalian species—a point
which has a profound relevance on translational studies on
brain development and its disorders. Indeed, observations on
a precocial species, the macaque, have demonstrated
GABAergic inhibition by blocking GABAARs in the hippocampus
ex utero during the last trimester of gestation (Khazipov et al.,
2001). In contrast to primates and the guinea pig, which have
high levels of KCC2 in cortical neurons much before birth (Riv-
era et al., 1999; Vanhatalo et al., 2005; Sedmak et al., 2016;
Spoljaric et al., 2017), rats and mice are both altricial rodents,
i.e., are born at a very immature stage of cortical development,
which corresponds to human postconceptional weeks (PCWs)
25–27 (Clancy et al., 2001). In the human cortex, strong devel-
opmental upregulation of KCC2 mRNA takes place between
the beginning of the third trimester and approximately the third
postnatal month (Vanhatalo et al., 2005; Sedmak et al., 2016),
and at PCW 25, most human cortical neurons express KCC2
protein (Sedmak et al., 2016). When setting our data into the
context of this cross-species calibration of developmental
age, aberrations in cortical KCC2 functions, such as those
caused by epilepsy mutations (Puskarjov et al., 2014; Kahle
et al., 2014; Stödberg et al., 2015; Saito et al., 2017), are likely
to interfere with activity-dependent neuronal wiring within a pro-
longed (15 weeks) prenatal time window in humans. In addi-
tion to compromised neuronal Cl extrusion as such, it is also
possible that the development of the epilepsy phenotype has
at least some of its roots in aberrant prenatal GDPs as
demonstrated by Khalilov et al. (2011), with consequent distur-
bances in the development of the hippocampal circuitry (see
Introduction).
In summary, our study shows that functional KCC2 is ex-
pressed at a surprisingly early developmental stage in the
CA3 region of the hippocampus, where it exerts a significant re-
straining influence on CA3-driven network events, the GDPs.
An interesting question for future research is whether the pres-
ence of transport-functional KCC2 is tightly involved in the
ontogeny of multiregional spontaneous activity patterns, analo-
gous to GDPs (Ben-Ari et al., 2007; Blankenship and Feller,
2010).STAR+METHODS
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Antibodies
Anti-K+/Cl Cotransporter (KCC2) Antibody Merck Millipore Cat #: 07-432, RRID:AB_310611
Alexa Fluor 568 goat anti-rabbit IgG (H+L) Thermo Fisher Cat #: A11036, RRID:AB_10563566
DAPI Thermo Fisher Cat #: D1306, RRID:AB_2629482
Streptavidin conjugated to Alexa Fluor 488 Thermo Fisher Cat #: S11223, RRID:AB_2336881
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Biocytin Sigma Cat #: B4261
Bumetanide Tocris Cat #: 3108
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D-AP5 Tocris Cat #: 0106
DMSO Sigma-Aldrich Cat #: D8418
DPNI-gaged GABA Tocris Cat #: 2991
8-DMAQ GABA Peter Dalco, Paris,
Descartes University
N/A
Fluoromount-G Thermo Fisher Cat #: 00-4958-02
Gramicidin Sigma-Aldrich Cat #: G0550000
Picrotoxin Tocris Cat #: 1128
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Experimental Models: Organisms/Strains
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Mouse: GAD67-GFP Tamamaki et al., 2003 N/A
Mouse: KCC2 / Vilen et al., 2001 N/A
Rat: Wistar (RccHan:WIST) Envigo N/A
Software and Algorithms
Clampfit Molecular Devices https://www.moleculardevices.com/
FIJI Schindelin et al., 2012 http://fiji.sc/
SPSS statistics IBM https://www.ibm.com/products/spss-statistics
MiniAnalysis Synaptosoft http://www.synaptosoft.com/MiniAnalysis/
Patchmaster HEKA https://www.heka.com/
WinEDR Stratchlyde http://spider.science.strath.ac.uk/sipbs/software_ses.htmCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to andwill be provided by the LeadContact, Kai Kaila
(kai.kaila@helsinki.fi).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Wistar rats (P0-2, P5 and P17), ICR mice (P0-1) and KCC2+/+, KCC2/ (Vilen et al., 2001; Li et al., 2007; Puskarjov et al., 2014) and
GAD67-GFP (Tamamaki et al., 2003) mice (E17.5-18.5) of either sex were used for the experiments. KCC2 full knock-out mice die at
birth due to respiratory failure (H€ubner et al., 2001), thus the experiments with KCC2/ mice were limited to the above prenatale1 Cell Reports 26, 1073–1081.e1–e3, January 29, 2019
period (see also Khalilov et al., 2011). For the collection of mouse embryos, timed pregnant mice dams were anesthetized with halo-
thane and pups were delivered with C-section. Animals were housed in a conventional animal facility with a 12:12-hour light-dark
cycle. The animals had access to food and water ad libitum. All experiments were approved by the Local Animal Ethics Committee
of the University of Helsinki.
METHOD DETAILS
Hippocampal preparations
For the preparation of hippocampal slices, following decapitation, the brain was quickly removed and immersed into ice cold (< 4C)
cutting solution containing in mM: 87 NaCl, 2.5 KCl, 0.5 CaCl2, 25 NaHCO3, 1.25 NaH2PO4, 7 MgCl2, 50 sucrose, and 25 D-glucose
(310 ± 5 mOsm). Horizontal brain slices (400-450 mm-thick) containing the ventral hippocampus in transverse section were cut using
a vibrating microtome (7000 SMZ-2; Campden Instruments). To obtain intact hippocampal preparations (Khalilov et al., 1997a) from
mouse embryos, brains were dissected in ice-cold cutting solution. After removing the cerebellum, the hemispheres were separated.
The deeper parts of the brain (brainstem, midbrain, and striatum) were carefully removed and the hippocampi were gently separated
from the neocortex using two spatulas. Both the acute hippocampal slices and intact hippocampi were left to recover for 1 hr at 34C
in standard solution containing in mM: 124 NaCl, 3 KCl, 2 CaCl2, 25 NaHCO3, 1.1 NaH2PO4, 1.3 MgSO4, and 10 D-glucose (300 ±
5 mOsm), after which they were stored in room temperature. All the extracellular solutions used in the study were equilibrated
with carbogen (95% O2, 5% CO2).
Electrophysiological recordings
After recovery, hippocampal preparations were transferred to a submerged recording chamber maintained at 32 ± 1C. The prep-
arations were constantly perfused with standard physiological solution in which [K+] was 3.5 mM (rat) and 4 mM (mouse). Perfusion
rates of 3.5 ml/min or 5.0 ml/min were used for slices and hippocampi, respectively. The following drugs (all from Tocris) were sup-
plemented to the extracellular solution when indicated: D-AP5 20 mM, CNQX 10 mM, TTX 0.5 mM, picrotoxin 100 mM, bumetanide
2.5 mM or 10 mM and VU0463271 10 mM. Bumetanide and VU0463271 were taken from 100 and 50 mM DMSO stocks, respectively.
The DMSO vehicle (0.02%–0.1%) did not affect GDPs in either rats or mice (rats, fold change: 1.01 [IQR 0.87 – 1.15], [n = 6], p = 0.753;
KCC2+/+ mice, fold change: 1.001 [IQR 0.81 – 1.67], [n = 6], p = 0.6, Wilcoxon signed-rank test).
Local field-potential recordings were obtained either with a custom-made amplifier or an EXT-02B amplifier (npi electronic GmbH),
using thin-filament glass-capillary pipettes (tip diameter 3-8 mm) filled with 150 mM NaCl placed in the pyramidal layer of area CA3.
Data were stored using WinEDR (Strathclyde Electrophysiology) with a sampling rate of 2-5 kHz, 5 kHz low-pass filtering and 1000x
amplification.
Single-cell recordings from visually-identified CA3 pyramidal neurons were obtained at a sampling rate of 20–50 kHz using an EPC
10 patch-clamp amplifier running Patchmaster software (HEKA). Borosilicate patch pipette resistance ranged from 3 to 6 MU. All
voltages have been corrected for the respective liquid junction potentials (LJP). Series-resistance compensation (up to 50%)
was performed online.
For whole-cell voltage-clamp recordings of sIPSCs, all cells included in the analyses had a resting membrane potential more
negative than 55 mV and a stable holding current. Recordings in which the access resistance (Ra) was higher than 30 MU or
changed > 30% were not included in the analysis. The patch pipettes were filled with the following solution (in mM): 140 CsCl,
10 HEPES, 5 EGTA, 4 NaCl, 1 CaCl2, 2 Mg-ATP, 5 QX314 bromide (pH adjusted to 7.2 with CsOH, 287 ± 5 mOsm, calculated
LJP 3.9 mV). Neurons were held at a holding potential of 70 mV and ionotropic glutamate receptor blockers D-AP5 and CNQX
were added to the extracellular solution.
Recordings of pyramidal neuron spiking were performed in loose cell-attached configuration (seal resistance 20-30 MU), using
patch pipettes filled with extracellular solution. Baseline spiking rates were recorded with the DMSO vehicle in the extracellular
solution.
To assess the efficacy of Cl- extrusion in neonatal CA3 pyramidal neurons, we utilized our standard assaywhere a constant Cl- load
is imposed on the neuron via a pipette (5-6 MU tip resistance) patched onto the soma in whole-cell configuration (Khirug et al., 2005;
Li et al., 2007; Puskarjov et al., 2015; Puskarjov et al., 2017; Spoljaric et al., 2017). In the presence of active Cl- extrusion in the den-
dritic compartment, the deviation of the measured EGABA from the EGABA-GHK predicted by the GHK voltage equation for Cl
- and
HCO3
- (the two anions permeating GABAARs), becomes more negative with increasing distance from the somatic load (Khirug
et al., 2005; Chamma et al., 2013). The pipette solution which had a Cl- concentration of 19 mM consisted of (in mM): 18 KCl,
111 K-gluconate, 0.5 CaCl2, 2 NaOH, 10 D-glucose, 10 HEPES, 2 Mg-ATP, 5 BAPTA and 0.1 Alexa Fluor 488; pH was adjusted to
7.3 with KOH, 283 ± 5mOsm, calculated LJP 14mV. Under these conditions, EGABA-GHK is set to47.7mV. The extracellular solution
contained D-AP5, CNQX, and bumetanide (2.5 mM). GABAA receptor-mediated currents were elicited using local UV-photolysis
(372 nm, 1-5 ms flash, 2 mW) of caged GABA (DPNI-GABA [Tocris] or 8-DMAQ-GABA [a kind gift of Peter Dalko, Paris Descartes
University]) (0.5-1 mM). Caged GABA was dissolved with the above drugs and delivered to the slice at a flow rate of 1 ml/min via
an UltraMicroPump II equipped with a syringe and a 100 mm inner tip-diameter quartz needle (WPI). EGABA values were determined
from current–voltage plots, obtained by sequentially stepping the membrane potential from the holding potential of 65 mV first
to95 mV for 700 ms and to a total six different levels with 10 mV increments and a 10 s step interval. Caged GABA was photolyzedCell Reports 26, 1073–1081.e1–e3, January 29, 2019 e2
120 ms after the start of each voltage step to evoke GABAAR-mediated currents at the soma and on the apical dendrite at a distance
of 50 or 200 mm. Apical dendrites were traced using confocal microscopy of the Alexa Fluor 488 signal. In neurons where dendritic
uncaging was performed at 200 mm from the soma (see Results), control EGABA values were recorded in the presence of DMSO
vehicle after which the perfusion solution was switched to that containing VU0463271 for 15 min before EGABA values were deter-
mined in the same neuron. To ensure a constant Cl- load from the pipette, recordings with change inRa less than 20%were accepted
for analysis.
In gramicidin-perforated patch recordings (Kyrozis andReichling, 1995) of GABAergicmIPSCs the pipette solution consisted of the
following (in mM): 55 K2SO4, 49 KCl, 0.5 CaCl2, 5 EGTA, 10 HEPES and 0.1 Alexa Fluor 488 (pH adjusted to 7.2 with KOH, osmolarity
adjusted with sucrose to 316mOsm, calculated LJP 8mV). Gramicidin (Sigma) (5 mg/ml) was added fresh to the pipette solution. The
extracellular solution was supplemented with TTX, D-AP5 and CNQX. Recordings were started after the access stabilized. Access
was monitored throughout the recording. To minimize clamping errors, pyramidal neurons were held at the potential where the hold-
ing current was zero, and kept at this potential throughout the recording. After a baseline of 5min, VU0463271 was applied for 10 min
via the bath perfusion. In the control recordings, DMSO (0.2 ml/ml) was applied instead of VU0463271.
Analysis of electrophysiological recordings
All events clearly distinguishable as GDPs were manually detected and their area (mV3ms) was quantified using numerical integra-
tion for each event in Clampfit (Molecular Devices). The event areaswere assigned to 10 s bins according to the temporal sequence of
the events to obtain the total area for each bin. For detailed analysis of the effect of VU0463271 on the frequency and analysis of
GDPs, see Figure S3. IPSCs were analyzed with Mini Analysis (Synaptosoft) using a threshold of four-five 3 baseline RMS noise.
Spiking frequencies recorded in loose cell-attached configuration were detected with WinEDR (Strathclyde). MUA was detected
with Clampfit, after band-pass filtering > 400 and < 4000 Hz, using a threshold of 3.5 SD x baseline noise.
Immunohistochemistry
Brains from E18.5 KCC2/, KCC2+/+ and GAD67-GFP mice were fixed for two nights in PFA (4%, in PBS, pH 7.4) at +4C,
embedded in Tissue-Tek (Sakura Finetek, NL) and cut into 40 mm horizontal cryosections on a Leica CM1900 cryostat. The sections
were washed (33 5 min in PBS), and blocking and was done in 3% BSA, 0.3% Triton-X, and 10% goat serum in PBS. The sections
were incubated at +4C overnight in blocking solution with the primary antibody against KCC2 (07-432, Millipore, 1:1000), and sub-
sequently washed (33 5 min in PBS) and incubated 2 hr in room temperature with the secondary antibody (Alexa Fluor 568, Thermo
Fisher, 1:500) in modified blocker solution (1% BSA, 0.3% Triton-X, 10% goat serum in PBS). The sections were then washed
(3 3 5 min in PBS) and nuclei were visualized with DAPI (4’, 6-Diamino-2-Phenylindole, Thermo Fisher, 1:2000 in PBS, 10 min incu-
bation in room temperature). After the final washes the sections were mounted on glass slides with FluoromountG (Thermo Fisher).
For analysis of KCC2 immunostaining, approximately 20 interneurons and pyramidal neurons per GAD67-GFP brain slice (n = 10 sli-
ces) were selected. The images were analyzed in FIJI (Schindelin et al., 2012). After outlining the neurons, the ROIs were overlaid on
the KCC2 staining from the same slice. Neurons that showed KCC2 in the vicinity of the plasma membrane were marked as KCC2
positive. In some experiments, neurons from P0-1 ICR mouse acute brain slices (n = 7 slices) were filled with biocytin to better visu-
alize somata for detection of KCC2 expression. For post hoc staining of individual neurons, biocytin (Sigma, 2.4 mg/ml) was added to
the pipette solution containing (in mM) 29 KCl, 101 K-gluconate, 0.5 CaCl2, 5 BAPTA, 10 HEPES, 10 glucose, 2Mg-ATP, and 2 NaOH,
with pH adjusted to 7.3 with KOH (280 ± 5 mOsm). Cells were filled for 2-5 min in the whole cell current-clamp configuration (I = 0 pA)
to allow biocytin to diffuse into the neuron. Slices were post-fixed in PFA (4%, in PBS, pH 7.4) at +4Covernight before staining. All the
immunostainings were performed as in the cryosections from the embryos (see above). To visualize the biocytin, streptavidin-con-
jugated Alexa Fluor 488 (Thermo Fisher, 1:500) was added during the incubation with secondary antibodies. Images were taken using
a Zeiss LSM 700 confocal microscope, equipped with LD LCI Plan-Apochromat 25x/0.8 ImmCorr and LD LCI Plan-Neofluar 63x/1.3
Imm Corr objectives.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data are presented asmedian values with interquartile range (IQR). The n values provided in the figure panels or in the text indicate
the number of cells or slices in single-cell and LFP recordings, respectively. Statistical analysis was done with SPSS Statistics (IBM).
Wilcoxon signed-rank test and Mann-Whitney U test were used for statistical analysis between paired and independent samples,
respectively. Friedman’s two-way analysis of variance by ranks test was used to analyze the significance of multiple paired samples
(Figure 2C). p values below 0.05 were considered as statistically significant, except in Figure 2C, where a Bonferroni adjusted p value
of 0.025 was used to correct for false positives in multiple post hoc comparisons with Wilcoxon signed-rank test.
In single-cell recordings on VU0463271 drug actions, data were normalized to the last 5 min of pre-application baseline. In LFP
experiments, the last 10 min of baseline were used for normalization in rats and, due to the much lower frequency of GDPs, to
the last 20 min in mice. Quantification of the effect of bath-applied VU0463271 on all presented parameters is described as median
from 10-15 min (whole-cell and loose cell-attached) or median from 5-10 min (gramicidin-perforated patch) after drug application
in single-cell recordings median from 10-20 min in rat LFP recordings and median from 10-30 min in mouse LFP recordings. Quan-
tification of DMSO effects on all parameters was done in the same time window as the drug effects.e3 Cell Reports 26, 1073–1081.e1–e3, January 29, 2019
